Real-time enrollment status for this end-stage renal disease clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:06 PM UTC
| NCT Number | NCT05908084 |
| Recruiting Status | Recruiting |
| Condition | End-Stage Renal Disease |
| Phase | Clinical Trial |
| Target Enrollment | 150 participants |
| Active Locations | 32 sites in the US |
| Sponsor | Humacyte, Inc. |
| Last Updated on CT.gov | March 18, 2025 (Mar 18, 2025) |
As of March 2, 2026: Clinical trial NCT05908084 is currently recruiting participants. This clinical trial study for end-stage renal disease is actively seeking new participants at 32 locations across the United States. The study is sponsored by Humacyte, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05908084 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 32 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05908084 was last updated Mar 18, 2025 (March 18, 2025). HelloStudys verifies this status automatically.